Hantavirus cases spark surge in pharma and biotech stocks — here’s why
CNBC
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC